Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations

Srgjan Civciristov, Andrew M. Ellisdon, Ryan Suderman, Cindy K. Pon, Bronwyn A. Evans, Oded Kleifeld, Steven J. Charlton, William S. Hlavacek, Meritxell Canals, Michelle L. Halls

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Abstract

G protein-coupled receptors (GPCRs) are the largest class of cell surface signaling proteins, participate in nearly all physiological processes, and are the targets of 30% of marketed drugs. Typically, nanomolar to micromolar concentrations of ligand are used to activate GPCRs in experimental systems. We detected GPCR responses to a wide range of ligand concentrations, from attomolar to millimolar, by measuring GPCR-stimulated production of cyclic adenosine monophosphate (cAMP) with high spatial and temporal resolution. Mathematical modeling showed that femtomolar concentrations of ligand activated, on average, 40% of the cells in a population provided that a cell was activated by one to two binding events. Furthermore, activation of the endogenous β2-adrenergic receptor (β2AR) and muscarinic acetylcholine M3 receptor (M3R) by femtomolar concentrations of ligand in cell lines and human cardiac fibroblasts caused sustained increases in nuclear translocation of extracellular signal-regulated kinase (ERK) and cytosolic protein kinase C (PKC) activity, respectively. These responses were spatially and temporally distinct from those that occurred in response to higher concentrations of ligand and resulted in a distinct cellular proteomic profile. This highly sensitive signaling depended on the GPCRs forming preassembled, higher-order signaling complexes at the plasma membrane. Recognizing that GPCRs respond to ultralow concentrations of neurotransmitters and hormones challenges established paradigms of drug action and provides a previously unappreciated aspect of GPCR activation that is quite distinct from that typically observed with higher ligand concentrations.

Original languageEnglish
Article numbereaan1188
Number of pages22
JournalScience Signaling
Volume11
Issue number551
DOIs
Publication statusPublished - 9 Oct 2018

Cite this

Civciristov, Srgjan ; Ellisdon, Andrew M. ; Suderman, Ryan ; Pon, Cindy K. ; Evans, Bronwyn A. ; Kleifeld, Oded ; Charlton, Steven J. ; Hlavacek, William S. ; Canals, Meritxell ; Halls, Michelle L. / Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations. In: Science Signaling. 2018 ; Vol. 11, No. 551.
@article{919b95988f434e649159849a9144229f,
title = "Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations",
abstract = "G protein-coupled receptors (GPCRs) are the largest class of cell surface signaling proteins, participate in nearly all physiological processes, and are the targets of 30{\%} of marketed drugs. Typically, nanomolar to micromolar concentrations of ligand are used to activate GPCRs in experimental systems. We detected GPCR responses to a wide range of ligand concentrations, from attomolar to millimolar, by measuring GPCR-stimulated production of cyclic adenosine monophosphate (cAMP) with high spatial and temporal resolution. Mathematical modeling showed that femtomolar concentrations of ligand activated, on average, 40{\%} of the cells in a population provided that a cell was activated by one to two binding events. Furthermore, activation of the endogenous β2-adrenergic receptor (β2AR) and muscarinic acetylcholine M3 receptor (M3R) by femtomolar concentrations of ligand in cell lines and human cardiac fibroblasts caused sustained increases in nuclear translocation of extracellular signal-regulated kinase (ERK) and cytosolic protein kinase C (PKC) activity, respectively. These responses were spatially and temporally distinct from those that occurred in response to higher concentrations of ligand and resulted in a distinct cellular proteomic profile. This highly sensitive signaling depended on the GPCRs forming preassembled, higher-order signaling complexes at the plasma membrane. Recognizing that GPCRs respond to ultralow concentrations of neurotransmitters and hormones challenges established paradigms of drug action and provides a previously unappreciated aspect of GPCR activation that is quite distinct from that typically observed with higher ligand concentrations.",
author = "Srgjan Civciristov and Ellisdon, {Andrew M.} and Ryan Suderman and Pon, {Cindy K.} and Evans, {Bronwyn A.} and Oded Kleifeld and Charlton, {Steven J.} and Hlavacek, {William S.} and Meritxell Canals and Halls, {Michelle L.}",
year = "2018",
month = "10",
day = "9",
doi = "10.1126/scisignal.aan1188",
language = "English",
volume = "11",
journal = "Science Signaling",
issn = "1945-0877",
publisher = "American Association for the Advancement of Science (AAAS)",
number = "551",

}

Civciristov, S, Ellisdon, AM, Suderman, R, Pon, CK, Evans, BA, Kleifeld, O, Charlton, SJ, Hlavacek, WS, Canals, M & Halls, ML 2018, 'Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations', Science Signaling, vol. 11, no. 551, eaan1188. https://doi.org/10.1126/scisignal.aan1188

Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations. / Civciristov, Srgjan; Ellisdon, Andrew M.; Suderman, Ryan; Pon, Cindy K.; Evans, Bronwyn A.; Kleifeld, Oded; Charlton, Steven J.; Hlavacek, William S.; Canals, Meritxell; Halls, Michelle L.

In: Science Signaling, Vol. 11, No. 551, eaan1188, 09.10.2018.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations

AU - Civciristov, Srgjan

AU - Ellisdon, Andrew M.

AU - Suderman, Ryan

AU - Pon, Cindy K.

AU - Evans, Bronwyn A.

AU - Kleifeld, Oded

AU - Charlton, Steven J.

AU - Hlavacek, William S.

AU - Canals, Meritxell

AU - Halls, Michelle L.

PY - 2018/10/9

Y1 - 2018/10/9

N2 - G protein-coupled receptors (GPCRs) are the largest class of cell surface signaling proteins, participate in nearly all physiological processes, and are the targets of 30% of marketed drugs. Typically, nanomolar to micromolar concentrations of ligand are used to activate GPCRs in experimental systems. We detected GPCR responses to a wide range of ligand concentrations, from attomolar to millimolar, by measuring GPCR-stimulated production of cyclic adenosine monophosphate (cAMP) with high spatial and temporal resolution. Mathematical modeling showed that femtomolar concentrations of ligand activated, on average, 40% of the cells in a population provided that a cell was activated by one to two binding events. Furthermore, activation of the endogenous β2-adrenergic receptor (β2AR) and muscarinic acetylcholine M3 receptor (M3R) by femtomolar concentrations of ligand in cell lines and human cardiac fibroblasts caused sustained increases in nuclear translocation of extracellular signal-regulated kinase (ERK) and cytosolic protein kinase C (PKC) activity, respectively. These responses were spatially and temporally distinct from those that occurred in response to higher concentrations of ligand and resulted in a distinct cellular proteomic profile. This highly sensitive signaling depended on the GPCRs forming preassembled, higher-order signaling complexes at the plasma membrane. Recognizing that GPCRs respond to ultralow concentrations of neurotransmitters and hormones challenges established paradigms of drug action and provides a previously unappreciated aspect of GPCR activation that is quite distinct from that typically observed with higher ligand concentrations.

AB - G protein-coupled receptors (GPCRs) are the largest class of cell surface signaling proteins, participate in nearly all physiological processes, and are the targets of 30% of marketed drugs. Typically, nanomolar to micromolar concentrations of ligand are used to activate GPCRs in experimental systems. We detected GPCR responses to a wide range of ligand concentrations, from attomolar to millimolar, by measuring GPCR-stimulated production of cyclic adenosine monophosphate (cAMP) with high spatial and temporal resolution. Mathematical modeling showed that femtomolar concentrations of ligand activated, on average, 40% of the cells in a population provided that a cell was activated by one to two binding events. Furthermore, activation of the endogenous β2-adrenergic receptor (β2AR) and muscarinic acetylcholine M3 receptor (M3R) by femtomolar concentrations of ligand in cell lines and human cardiac fibroblasts caused sustained increases in nuclear translocation of extracellular signal-regulated kinase (ERK) and cytosolic protein kinase C (PKC) activity, respectively. These responses were spatially and temporally distinct from those that occurred in response to higher concentrations of ligand and resulted in a distinct cellular proteomic profile. This highly sensitive signaling depended on the GPCRs forming preassembled, higher-order signaling complexes at the plasma membrane. Recognizing that GPCRs respond to ultralow concentrations of neurotransmitters and hormones challenges established paradigms of drug action and provides a previously unappreciated aspect of GPCR activation that is quite distinct from that typically observed with higher ligand concentrations.

UR - http://www.scopus.com/inward/record.url?scp=85054774815&partnerID=8YFLogxK

U2 - 10.1126/scisignal.aan1188

DO - 10.1126/scisignal.aan1188

M3 - Article

VL - 11

JO - Science Signaling

JF - Science Signaling

SN - 1945-0877

IS - 551

M1 - eaan1188

ER -